Association of cardiovascular emerging risk factors with acute coronary syndrome and stroke: A case-control study
Corresponding Author
José Manuel Martínez Linares RN, PhD Candidate
Virgen de las Nieves Universitary Hospital, Granada, Spain
Correspondence address: José Manuel Martínez Linares, Virgen de las Nieves Universitary Hospital, Emergencies and Critical Care Unit, 2 Fuerzas Armadas Avenue, Grenada 18014, Spain. Email: [email protected]Search for more papers by this authorRafael Guisado Barrilao MD, PhD
School of Health Sciences, University of Granada, Granada, Spain
Search for more papers by this authorFrancisco Manuel Ocaña Peinado PhD
School of Pharmacy, University of Granada, Granada, Spain
Search for more papers by this authorFrancisco Javier Salgado Parreño MD, PhD
Laboratory Unit, Hospital of Motril, Granada, Spain
Search for more papers by this authorCorresponding Author
José Manuel Martínez Linares RN, PhD Candidate
Virgen de las Nieves Universitary Hospital, Granada, Spain
Correspondence address: José Manuel Martínez Linares, Virgen de las Nieves Universitary Hospital, Emergencies and Critical Care Unit, 2 Fuerzas Armadas Avenue, Grenada 18014, Spain. Email: [email protected]Search for more papers by this authorRafael Guisado Barrilao MD, PhD
School of Health Sciences, University of Granada, Granada, Spain
Search for more papers by this authorFrancisco Manuel Ocaña Peinado PhD
School of Pharmacy, University of Granada, Granada, Spain
Search for more papers by this authorFrancisco Javier Salgado Parreño MD, PhD
Laboratory Unit, Hospital of Motril, Granada, Spain
Search for more papers by this authorAbstract
In this study, we estimated the risk of acute coronary syndrome and stroke associated with several emerging cardiovascular risk factors. This was a case-control study, where an age - and sex-matched acute coronary syndrome group and stroke group were compared with controls. Demographic and clinical data were collected through patient interviews, and blood samples were taken for analysis. In the bivariate analysis, all cardiovascular risk factors analyzed showed as predictors of acute coronary syndrome and stroke, except total cholesterol and smoking. In the multivariate logistic regression model for acute coronary syndrome, hypertension and body mass index, N-terminal section brain natriuretic peptide and pregnancy-associated plasma protein-A were independent predictors. For stroke, the predictors were hypertension, diabetes mellitus, body mass index, and N-terminal section brain natriuretic peptide. Controlling for age, sex, and classical cardiovascular risk factors, N-terminal section brain natriuretic peptide and pregnancy-associated plasma protein-A were independent emerging cardiovascular risk factors for acute coronary syndrome, but pregnancy-associated plasma protein-A was not for stroke. High levels of cardiovascular risk factors in individuals with no episodes of cardiovascular disease requires the implementation of prevention programs, given that at least half of them are modifiable.
References
- Argimón JM, Jiménez J. Estudios de casos y controles. In: JM Argimón, J Jiménez (eds). Métodos de investigación clínica y epidemiológica ( 4th edn). Barcelona: Elsevier, 2013; 74–86.
- Bayes-Genis A, Conover CA, Overgaard MT et al. Pregnancy associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 2001; 345: 1022–1029.
- Clarke J, Lewington S, Lonn E et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37485 individuals. Arch. Intern. Med. 2010; 170: 1622–1631.
- Conover CA. Key questions and answers about pregnancy-associated plasma protein-A. Trends Endocrinol. Metab. 2012; 23: 242–249.
- Conover CA, Mason MA, Bale LK et al. Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development. Am. J. Physiol. Heart Circ. Physiol. 2010; 299: H284–H291.
- European Commission. 2012. Eurostat Public Health Database. [Cited 26 Nov 2013]. Available from URL: http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=hlth_cd_anr&lang=en.
- European Regional and Local Health Authorities. 2008. European Cardiovascular Disease Statistics. [Cited 13 May 2015]. Available from URL: http://www.euregha.net/2008-news/4-european-cardiovascular-disease-statistics-2008.
- Fialová L, Pilečková N, Bauer J et al. Pregnancy-associated plasma protein-A in patients with cerebrovascular diseases – a pilot study. Prague Med. Rep. 2006; 107: 37–45.
- Fiechter M, Ghadri JR, Jaguszewski M et al. Impact of inflammation on adverse cardiovascular events in patients with acute coronary syndromes. J. Cardiovasc. Med. (Hagerstown) 2013; 14: 807–814.
- van Gilder RL, Davidov DM, Stinehart KR et al. C-reactive protein and long-term ischemic stroke prognosis. J. Clin. Neurosci. 2014; 21: 547–553.
- Hajsadeghi S, Amin LK, Bakhshandeh H et al. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke. J. Stroke Cerebrovasc. Dis. 2013; 22: 554–560.
- Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288: 2015–2022.
- Hoyert D, Xu JD. 2012. Preliminary Data for 2011. [Cited 26 Nov 2013]. Available from URL: http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdf.
- Instituto Nacional de Estadística. 2012. Defunciones según la Causa de Muerte 2011. Tablas Nacionales. Defunciones por causas (lista reducida), sexo y edad. [Cited 3 Apr 2014]. Available from URL: http://www.ine.es/inebase/cgi/axi (In Spanish).
- Kara K, Gronewold J, Neumann T et al. B-type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification. Eur. J. Neurol. 2014; 21: 914–921.
- Lawrence JB, Oxvig C, Overgaard MT et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts in pregnancy-associated plasma protein-A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 3149–3153.
- Li Y, Zhou C, Zhou X et al. PAPP-A in cardiac and non-cardiac conditions. Clin. Chim. Acta 2013; 417: 67–72.
- Linssen GC, Bakker SJ, Voors AA et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur. Heart J. 2010; 31: 120–127.
- Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013; 31: 1281–1357.
- Martí-Carvajal AJ, Solà I, Lathyris D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst. Rev. 2015; 1: CD006612. DOI:10.1002/14651858.CD006612.pub3.
- Martínez JM, Guisado R, Ocaña FM, Salgado FJ. Modelos de estimación de riesgo cardiovascular y papel de enfermería en la prevención. Enferm Cardiol. 2014; 63: 44–48 (In Spanish).
- Mishra RK, Beatty AL, Jaganath R et al. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: The Heart and Soul Study. J. Am. Heart Assoc. 2014; 168: 931–939.
- Naess H, Nyland H, Idicula T et al. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. J. Stroke Cerebrovasc. Dis. 2013; 22: 435–440.
- Niu JM, Ma ZL, Xie C et al. Association of plasma B-type natriuretic peptide concentration with myocardial infarct size in patients with acute myocardial infarction. Genet. Mol. Res. 2014; 13: 6177–6183.
- Nogami M, Shiga J, Takatsu A et al. Immunohistochemistry of atrial natriuretic peptide in brain infarction. Histochem. J. 2001; 33: 87–90.
- Odden MC, Shlipak MG, Whitson HE et al. Risk factors for cardiovascular disease across the spectrum of older age: the Cardiovascular Health Study. Atherosclerosis 2014; 237: 336–342.
- Oluleye OW, Folsom AR, Nambi V et al. for the ARIC Study Investigators. Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann. Epidemiol. 2013; 23: 66–73.
- R Core Team. 2014. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2014. Vienna, Austria. Available from URL: http://www.r-project.org/.
- Rodríguez E, López B, López AM et al. Grupo de Investigación UCM 920030. Prevalencia de sobrepeso y obesidad en adultos españoles. Nutr. Hosp. 2011; 26: 355–363 (In Spanish).
- Sangiorgi G, Mauriello A, Bonanno E et al. Pregnancy-associated plasma protein-A is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques. A Link Between Inflammation and Cerebrovascular Events. J. Am. Coll. Cardiol. 2006; 47: 2201–2211.
- Sans S, Fitzgerald AP, Royo D et al. Calibración de la tabla SCORE de riesgo cardiovascular para España. Rev. Esp. Cardiol. 2007; 60: 476–485 (In Spanish).
- Soriguer F, Goday A, Bosch-Comas A et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the [email protected] Study. Diabetologia 2011; 55: 88–93.
- The Fifth Joint Task Force of The European Society of Cardiology and Other Societies On Cardiovascular Disease Prevention in Clinical Practice. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012). Eur. Heart J. 2012; 33: 1635–1701.
- World Health Organization. 2015. Cardiovascular diseases (CVDs). [Cited 8 Nov 2015]. Available from URL: http://www.who.int/mediacentre/factsheets/fs317/en.
- Yang H, Lin YP, Long Y et al. Predicting cardioembolic stroke with the B-type natriuretic peptide test: a systematic review and meta-analysis. J. Stroke Cerebrovasc. Dis. 2014; 23: 1882–1889.
- You L, Li L, Zhang F et al. A pilot study of the clinical relevance of the relationship between the serum level of pregnancy-associated plasma protein A and the degree of acute coronary syndrome. J. Int. Med. Res. 2010; 38: 625–632.
- Zylberstein DE, Bengtsson C, Bjorkelund C et al. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation 2004; 109: 601–606.